One-carbon metabolism pathway gene variants and risk of clear cell renal cell carcinoma in a chinese population

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Zhang, Lei ^a   Meng, Xiaoxin ^a   Ju, Xiaobing ^a   Cai, Hongzhou ^a   Li, Pu ^a   Cao, Qiang ^a   Shao, Pengfei ^a   Qin, Chao ^a   Yin, Changjun ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA;

ADULT; ALLELE; ARTICLE; CANCER RISK; CANCER STAGING; CARBON METABOLISM; CBS GENE; CHINA; CHINESE; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MTHFR GENE; MTR GENE; MTRR GENE; ONE CARBON METABOLISM; SHMT1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE; TYMS GENE; VENOUS BLOOD; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CANCER GRADING; CASE CONTROL STUDY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; KIDNEY TUMOR; METABOLISM; PATHOLOGY; RISK;

AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, RENAL CELL; CASE-CONTROL STUDIES; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; ODDS RATIO; POLYMORPHISM, GENETIC;

EID: 84896728871     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081129     Document Type: Article

References (37)

1. Siegel R, Ward E, Brawley O, Jemal A (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61: 212-236.
2. Chow WH, Dong LM, Devesa SS (2010) Epidemiology and risk factors for kidney cancer. Nat Rev Urol 7: 245-257.
3. Mathew A, Devesa SS, Fraumeni JF, Jr., Chow WH (2002) Global increases in kidney cancer incidence, 1973-1992. Eur J Cancer Prev 11: 171-178. (Pubitemid 34478435)
4. Hirata H, Hinoda Y, Nakajima K, Kikuno N, Suehiro Y, et al. (2009) The bcl2 - 938CC genotype has poor prognosis and lower survival in renal cancer. J Urol 182: 721-727.
5. Lin J, Horikawa Y, Tamboli P, Clague J, Wood CG, et al. (2010) Genetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma. Carcinogenesis 31: 1805-1812.
6. Kleinrath T, Gassner C, Lackner P, Thurnher M, Ramoner R (2007) Interleukin-4 promoter polymorphisms: a genetic prognostic factor for survival in metastatic renal cell carcinoma. J Clin Oncol 25: 845-851. (Pubitemid 350002885)
7. Kawai Y, Sakano S, Korenaga Y, Eguchi S, Naito K (2007) Associations of single nucleotide polymorphisms in the vascular endothelial growth factor gene with the characteristics and prognosis of renal cell carcinomas. Eur Urol 52: 1147-1155. (Pubitemid 47332024)
8. Teodoridis JM, Strathdee G, Plumb JA, Brown R (2004) CpG-island methylation and epigenetic control of resistance to chemotherapy. Biochem Soc Trans 32: 916-917. (Pubitemid 39655503)
9. Shinojima T, Oya M, Takayanagi A, Mizuno R, Shimizu N, et al. (2007) Renal cancer cells lacking hypoxia inducible factor (HIF)-1alpha expression maintain vascular endothelial growth factor expression through HIF-2alpha. Carcinogenesis 28: 529-536. (Pubitemid 46523348)
10. Kawakami T, Okamoto K, Ogawa O, Okada Y (2003) Multipoint methylation and expression analysis of tumor suppressor genes in human renal cancer cells. Urology 61: 226-230. (Pubitemid 36151757)
11. Morrissey C, Martinez A, Zatyka M, Agathanggelou A, Honorio S, et al. (2001) Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma. Cancer Res 61: 7277-7281. (Pubitemid 32946526)
12. Eden A, Gaudet F, Waghmare A, Jaenisch R (2003) Chromosomal instability and tumors promoted by DNA hypomethylation. Science 300: 455. (Pubitemid 36444319)
13. Feinberg AP (2007) Phenotypic plasticity and the epigenetics of human disease. Nature 447: 433-440.
14. Moore LE, Hung R, Karami S, Boffetta P, Berndt S, et al. (2008) Folate metabolism genes, vegetable intake and renal cancer risk in central Europe. Int J Cancer 122: 1710-1715. (Pubitemid 351413416)
15. Gibson TM, Brennan P, Han S, Karami S, Zaridze D, et al. (2011) Comprehensive evaluation of one-carbon metabolism pathway gene variants and renal cell cancer risk. PLoS One 6: e26165.
16. Flores KG, Stidley CA, Mackey AJ, Picchi MA, Stabler SP, et al. (2012) Sex-specific association of sequence variants in CBS and MTRR with risk for promoter hypermethylation in the lung epithelium of smokers. Carcinogenesis 33: 1542-1547.
17. Shen M, Rothman N, Berndt SI, He X, Yeager M, et al. (2005) Polymorphisms in folate metabolic genes and lung cancer risk in Xuan Wei, China. Lung Cancer 49: 299-309. (Pubitemid 41139142)
18. Curtin K, Slattery ML, Ulrich CM, Bigler J, Levin TR, et al. (2007) Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of diet. Carcinogenesis 28: 1672-1679. (Pubitemid 47303944)
19. Cui LH, Yu Z, Zhang TT, Shin MH, Kim HN, et al. (2011) Influence of polymorphisms in MTHFR 677 C->T, TYMS 3R->2R and MTR 2756 A->G on NSCLC risk and response to platinum-based chemotherapy in advanced NSCLC. Pharmacogenomics 12: 797-808.
20. Shi Q, Zhang Z, Li G, Pillow PC, Hernandez LM, et al. (2005) Sex differences in risk of lung cancer associated with methylene-tetrahydrofolate reductase polymorphisms. Cancer Epidemiol Biomarkers Prev 14: 1477-1484. (Pubitemid 40807349)
21. Boccia S, Boffetta P, Brennan P, Ricciardi G, Gianfagna F, et al. (2009) Meta-analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and risk of head and neck and lung cancer. Cancer Lett 273: 55-61.
22. Mao R, Fan Y, Jin Y, Bai J, Fu S (2008) Methylenetetrahydrofolate reductase gene polymorphisms and lung cancer: a meta-analysis. J Hum Genet 53: 340-348.
23. Qin C, Cao Q, Ju X, Wang M, Meng X, et al. (2012) The polymorphisms in the VHL and HIF1A genes are associated with the prognosis but not the development of renal cell carcinoma. Ann Oncol 23: 981-989.
24. Yi P, Melnyk S, Pogribna M, Pogribny IP, Hine RJ, et al. (2000) Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J Biol Chem 275: 29318-29323. (Pubitemid 32043802)
25. Le Marchand L, Donlon T, Hankin JH, Kolonel LN, Wilkens LR, et al. (2002) B-vitamin intake, metabolic genes, and colorectal cancer risk (United States). Cancer Causes Control 13: 239-248. (Pubitemid 34438233)
26. Galbiatti AL, Ruiz MT, Raposo LS, Maniglia JV, Pavarino-Bertelli EC, et al. (2010) The association between CBS 844ins68 polymorphism and head and neck squamous cell carcinoma risk - a case-control analysis. Arch Med Sci 6: 772-779.
27. Leclerc D, Wilson A, Dumas R, Gafuik C, Song D, et al. (1998) Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria. Proc Natl Acad Sci U S A 95: 3059-3064. (Pubitemid 28135854)
28. Shaw GM, Lu W, Zhu H, Yang W, Briggs FB, et al. (2009) 118 SNPs of folate-related genes and risks of spina bifida and conotruncal heart defects. BMC Med Genet 10: 49.
29. Skibola CF, Forrest MS, Coppede F, Agana L, Hubbard A, et al. (2004) Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma. Blood 104: 2155-2162. (Pubitemid 39297871)
30. Mandola MV, Stoehlmacher J, Zhang W, Groshen S, Yu MC, et al. (2004) A 6 bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratumoral TS mRNA levels. Pharmacogenetics 14: 319-327. (Pubitemid 38638919)
31. Ulrich CM, Curtin K, Potter JD, Bigler J, Caan B, et al. (2005) Polymorphisms in the reduced folate carrier, thymidylate synthase, or methionine synthase and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 14: 2509-2516. (Pubitemid 41752708)
32. Mizutani Y, Wada H, Yoshida O, Fukushima M, Nonomura M, et al. (2003) Significance of thymidylate synthase activity in renal cell carcinoma. Clin Cancer Res 9: 1453-1460. (Pubitemid 36418401)
33. Zhong R, Liu L, Zou L, Sheng W, Zhu B, et al. (2013) Genetic variations in the TGFbeta signaling pathway, smoking and risk of colorectal cancer in a Chinese population. Carcinogenesis 34: 936-942.
34. Liu L, Wu C, Wang Y, Zhong R, Wang F, et al. (2011) Association of candidate genetic variations with gastric cardia adenocarcinoma in Chinese population: a multiple interaction analysis. Carcinogenesis 32: 336-342.
35. Xu J, Turner A, Little J, Bleecker ER, Meyers DA (2002) Positive results in association studies are associated with departure from Hardy-Weinberg equilibrium: hint for genotyping error? Hum Genet 111: 573-574. (Pubitemid 36075091)
36. Llorca J, Prieto-Salceda D, Combarros O, Dierssen-Sotos T, Berciano J (2005) [Competing risks of death and Hardy-Weinberg equilibrium in case-control studies of gene-disease association]. Gac Sanit 19: 321-324.
37. Wittke-Thompson JK, Pluzhnikov A, Cox NJ (2005) Rational inferences about departures from Hardy-Weinberg equilibrium. Am J Hum Genet 76: 967-986. (Pubitemid 40705433)